This program aims to develop and optimise bioseparation technologies and platforms which overcome specificity, throughput and quality challenges.
This program spans separatory activities related to cells, tissues, tissue products, fluids, biologics and small molecules.
Indicative outcomes include:
- Novel surfaces and processes that increase target specificity
- Purification of regenerative compounds from bodily fluids, cells and tissues
- Separation at scale for enhanced downstream manufacturing
- Well-defined parameters for manufacturing consistency
- Pathways to commercialising purified products
KEY PERSONNEL
Prof. Justin Cooper-White
Bioseparation Co-Lead
The University of Queensland
Prof. David Irving
Bioseparation Co-Lead
Australian Red Cross Lifeblood